Search Within

Richard D Carvajal

Formats
  1. Journal Article (86)
  2. Meeting Abstract (61)
  3. Book Section (1)
Groups
  1. Department of Medicine (100)
  2. Solid Tumor Oncology Division (98)
  3. Melanoma and Immunotherapeutics Service (57)
  4. GSK Faculty (50)
  5. Biostatistics Service (45)
  6. Epidemiology and Biostatistics (45)

More Groups

People
  1. Gary Schwartz (61)
  2. Jedd Wolchok (41)
  3. Paul Chapman (33)
  4. Mark Dickson (29)
  5. Katherine Panageas (22)
  6. Sandra D'Angelo (20)

More People

Years
  1. 2023 (1)
  2. 2020 (1)
  3. 2019 (2)
  4. 2018 (4)
  5. 2017 (1)
  6. 2016 (4)

More Years

Publications
  1. Journal of Clinical Oncology (57)
  2. Clinical Cancer Research (13)
  3. Annals of Oncology (4)
  4. Cancer (4)
  5. Pigment Cell & Melanoma Research (4)
  6. Annals of Surgical Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (58)
  2. American Association for Cancer Research (18)
  3. Elsevier Inc. (10)
  4. Wiley Blackwell (10)
  5. Springer (9)
  6. Lippincott Williams & Wilkins (7)

More Publishers

Results (148)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
    Journal Article

    Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase 1 dose-escalation study of 17-allylamino-17-demethoxygeldanamycin (17AAG) in combination with irinotecan in patients with solid tumors
    Meeting Abstract

    Tse, A. N.; Carvajal, R.; Shah, M.; Dials, H.; Fogel, M.; O'Reilly, E.; Chung, K.; Maki, R.; Wu, N.; Egorin, M.; more...
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis)
    Meeting Abstract

    Carvajal, R. D.; Tse, A.; Wu, N.; Gonen, M.; Lefkowitz, R.; Dials, H.; Barbi, A.; Mui, J.; Schwartz, G. K.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Targeting checkpoint kinase 1 in cancer therapeutics
    Journal Article

    Tse, A. N.; Carvajal, R.; Schwartz, G. K.
    Clinical Cancer Research (2007)

    Fulltext@MSK | Save
  • Possible role of edotecarin, a novel topoisomerase I inhibitor, in theraphy-related myelodysplastic syndrome
    Journal Article

    Carvajal, R. D.; Ilson, D.; Noy, A.
    Leukemia and Lymphoma (2007)

    Fulltext@MSK | Save
  • A non-randomized phase II study of sequential irinotecan (CPT) and flavopiridol (F) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Abou-Alfa, G. K.; Carvajal, R. D.; Chung, K. Y.; Ghossein, R. A.; Capanu, M.; Gonen, M.; Jacobs, G.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Aurora kinases: New targets for cancer therapy
    Journal Article

    Carvajal, R. D.; Tse, A.; Schwartz, G. K.
    Clinical Cancer Research (2006)

    Fulltext@MSK | Save
  • Ewing's sarcoma and primitive neuroectodermal family of tumors
    Journal Article

    Carvajal, R.; Meyers, P.
    Hematology/Oncology Clinics of North America (2005)

    Fulltext@MSK | Save